サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1428330

閉経後骨粗しょう症治療の世界市場レポート 2024

Postmenopausal Osteoporosis Treatment Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
閉経後骨粗しょう症治療の世界市場レポート 2024
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

閉経後骨粗しょう症治療の市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には5.4%の年間複合成長率（CAGR）で123億8,000万米ドルに成長すると予想されます。予測期間で予想される成長は、医療インフラの成長、スクリーニングプログラムの増加、精密医療アプローチ、骨粗しょう症治療におけるバイオシミラーの使用、女性の健康プログラムにおける骨の健康に焦点を当てた取り組み、デジタルヘルスの統合、そして再生医療のアプローチの探求などの要因に起因すると考えられます。予測期間の主な動向には、診断法の進歩、新薬開発、新たな治療法、医薬品開発のためのコラボレーション、人工知能（AI）の統合が含まれます。

骨粗しょう症の有病率の予測増加は、閉経後骨粗しょう症治療市場の成長を促進すると予想されます。骨量の減少と骨組織の弱体化を特徴とする骨粗しょう症は、骨折のリスクを高めます。 閉経後骨粗しょう症治療は、症状の予防または管理、骨折リスクの軽減、全体的な健康状態の向上において重要な役割を果たします。 Healthy Bones Australiaのレポートでは、骨粗しょう症または骨減少症に関連する骨折が2021年の178,439件から2022年には183,105件に増加していることが明らかになり、効果的な閉経後骨粗しょう症治療の必要性が強調されています。

肥満の蔓延は閉経後骨粗しょう症治療市場の拡大に寄与すると予想されます。過剰な体脂肪の蓄積を特徴とする肥満は、健康に悪影響を及ぼします。 閉経後骨粗しょう症治療は、骨密度を改善し、骨折リスクを軽減し、骨の健康を促進することにより、肥満の人にメリットをもたらします。英国政府の報告書では、2021年から2022年にかけて18歳以上の個人の25.9%が肥満であることが示されており、閉経後骨粗しょう症治療の大きな市場潜在力が強調されています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 市場促進要因・市場抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 市場規模と成長実績、2018～2023年
  • 市場規模と成長予測、2023～2028年、2033年

第6章 市場セグメンテーション

  • 世界の閉経後骨粗しょう症治療市場、薬剤タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • ビスホスホネート
  • ビタミンD3
  • エストロゲンアゴニスト/アンタゴニスト
  • ホルモン補充療法
  • 副甲状腺ホルモン療法
  • その他
  • 世界の閉経後骨粗しょう症治療市場、投与経路別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 経口
  • 非経口
  • その他
  • 世界の閉経後骨粗しょう症治療市場、流通チャネル別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 病院薬局
  • 小売薬局
  • その他

第7章 地域および国の分析

  • 世界の閉経後骨粗しょう症治療市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界の閉経後骨粗しょう症治療市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 閉経後骨粗しょう症治療市場の競合情勢
  • 閉経後骨粗しょう症治療市場の企業プロファイル
    • Pfizer Inc.
    • Johnson and Johnson
    • F. Hoffmann-La Roche AG
    • Merck and Co. Inc.
    • AbbVie Inc.

第31章 その他の大手および革新的な企業

  • Bayer AG
  • Novartis AG
  • Sanofi SA
  • Eli Lilly and Company
  • Amgen Inc.
  • Asahi Kasei Corporation
  • Viatris Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Mylan NV
  • Sandoz International GmbH
  • Fresenius Kabi AG
  • Daiichi Sankyo Company Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Cipla Inc.
  • Dr.Reddys Laboratories Ltd.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r14174

Postmenopausal osteoporosis treatment refers to medical interventions and strategies aimed at managing and preventing bone loss and fractures in women after menopause. Postmenopausal osteoporosis is characterized by decreased bone density and an increased susceptibility to fractures due to hormonal changes after menopause.

The main types of drugs used in postmenopausal osteoporosis treatment include bisphosphonates, vitamin D3, estrogen agonists or antagonists, hormone replacement therapy, parathyroid hormone therapy, and others. Bisphosphonates, a class of medications, are commonly used to treat various bone-related conditions, with osteoporosis being a notable example. These medications can be administered through oral, parenteral, and other routes, and they are available through various distribution channels, including hospital pharmacies, retail pharmacies, and others.

The postmenopausal osteoporosis treatment market research report is one of a series of new reports from The Business Research Company that provides postmenopausal osteoporosis treatment market statistics, including postmenopausal osteoporosis treatment industry global market size, regional shares, competitors with a postmenopausal osteoporosis treatment market share, detailed postmenopausal osteoporosis treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the postmenopausal osteoporosis treatment industry. This postmenopausal osteoporosis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The postmenopausal osteoporosis treatment market size has grown strongly in recent years. It will grow from $9.49 billion in 2023 to $10.03 billion in 2024 at a compound annual growth rate (CAGR) of 5.7%. The expansion observed in the historical period can be attributed to factors such as the aging population, the use of hormone replacement therapy, increased awareness of postmenopausal osteoporosis, efforts to reduce fracture risks, and the utilization of nutritional supplements.

The postmenopausal osteoporosis treatment market size is expected to see strong growth in the next few years. It will grow to $12.38 billion in 2028 at a compound annual growth rate (CAGR) of 5.4%. The anticipated growth in the forecast period can be attributed to factors such as healthcare infrastructure growth, increased screening programs, precision medicine approaches, the use of biosimilars in osteoporosis treatment, initiatives focused on bone health in women's health programs, the integration of digital health, and the exploration of regenerative medicine approaches. Major trends in the forecast period include advances in diagnostics, new drug development, emerging therapies, collaborations for drug development, and the integration of artificial intelligence (AI).

The projected increase in osteoporosis prevalence is expected to drive the growth of the postmenopausal osteoporosis treatment market. Osteoporosis, characterized by reduced bone mass and weakened bone tissue, poses an increased risk of fractures. Postmenopausal osteoporosis treatment plays a crucial role in preventing or managing the condition, reducing fracture risks, and enhancing overall health outcomes. A report from Healthy Bones Australia revealed a rise in fractures related to osteoporosis or osteopenia from 178,439 in 2021 to 183,105 in 2022, emphasizing the need for effective postmenopausal osteoporosis treatments.

The growing prevalence of obesity is anticipated to contribute to the expansion of the postmenopausal osteoporosis treatment market. Obesity, characterized by excessive body fat accumulation, negatively impacts health. Postmenopausal osteoporosis treatment offers benefits to individuals with obesity by improving bone density, reducing fracture risks, and promoting bone health. In England, a government report indicated that 25.9% of individuals aged 18 and older were obese in 2021-2022, emphasizing the significant market potential for postmenopausal osteoporosis treatments.

The growth of the postmenopausal osteoporosis treatment market is expected to be propelled by government initiatives focused on symptom management and disease treatment. These initiatives encompass policies, programs, or measures aimed at addressing specific health issues and achieving targeted goals. Notably, the Asia Pacific Consortium on Osteoporosis (APCO) introduced clinical practice guidelines in January 2021 for postmenopausal osteoporosis diagnosis, management, and screening. These guidelines, supported by government and other organizations, provide crucial information for patients' self-care and emphasize the need for monitoring and improving osteoporosis care quality.

Innovation in product offerings emerges as a prominent trend in the postmenopausal osteoporosis treatment market. Key market players are actively introducing new products to maintain their market positions. Theramex, a UK-based pharmaceutical company, launched Livogiva in January 2021, designed specifically for osteoporosis patients. This product expands the company's lineup, offering a range of treatments from prevention with calcium and vitamin D to advanced oral bisphosphonates with patient-friendly administration instructions.

Major companies in the postmenopausal osteoporosis treatment market are striving to gain a competitive edge through innovative products. Advanced bone-building medications, typically administered through injections to promote bone health and density, are a focus of development. In November 2023, Teva Pharmaceuticals Inc., a U.S-based pharmaceutical company, received FDA approval for Forteo (teriparatide injection), catering to postmenopausal women with osteoporosis at high fracture risk. The approval underscores the significance of innovative bone-building medications in treating osteoporosis in both men and women.

Major companies operating in the postmenopausal osteoporosis treatment market report are Pfizer Inc., Johnson and Johnson, F. Hoffmann-La Roche AG, Merck and Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi SA, Eli Lilly and Company, Amgen Inc., Asahi Kasei Corporation, Viatris Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Sandoz International GmbH, Fresenius Kabi AG, Daiichi Sankyo Company Ltd., Sun Pharmaceutical Industries Ltd., Cipla Inc., Dr.Reddys Laboratories Ltd., Hikma Pharmaceuticals PLC., Amneal Pharmaceuticals LLC, Zydus Lifesciences Ltd., Takeda Pharmaceutical Company Limited, Lupin Limited, Celltrion Inc., Biocon Limited, Accord Healthcare Ltd, Ligand Pharmaceuticals Incorporated, Torrent Pharmaceuticals Limited.

North America was the largest region in the postmenopausal osteoporosis treatment market in 2023. The regions covered in the postmenopausal osteoporosis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the postmenopausal osteoporosis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The postmenopausal osteoporosis treatment market consists of revenues earned by entities by providing screening and diagnosis, bone density testing, and risk assessment. The market value includes the value of related goods sold by the service provider or included within the service offering. The postmenopausal osteoporosis treatment market also includes sales of selective estrogen receptor modulators and osteoporosis drugs that are used for the treatment of postmenopausal osteoporosis. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Postmenopausal Osteoporosis Treatment Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on postmenopausal osteoporosis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for postmenopausal osteoporosis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The postmenopausal osteoporosis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Drug Type: Bisphosphonates; Vitamin D3; Estrogen Agonist Or Antagonist; Hormone Replacement Therapy; Parathyroid Hormone Therapy; Other Drug Types
  • 2) By Route Of Administration: Oral; Parenteral; Other Routes Of Administration
  • 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Other Distribution Channels
  • Companies Mentioned: Pfizer Inc.; Johnson and Johnson; F. Hoffmann-La Roche AG; Merck and Co. Inc.; AbbVie Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Postmenopausal Osteoporosis Treatment Market Characteristics

3. Postmenopausal Osteoporosis Treatment Market Trends And Strategies

4. Postmenopausal Osteoporosis Treatment Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Postmenopausal Osteoporosis Treatment Market Size and Growth

  • 5.1. Global Postmenopausal Osteoporosis Treatment Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Postmenopausal Osteoporosis Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Postmenopausal Osteoporosis Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Postmenopausal Osteoporosis Treatment Market Segmentation

  • 6.1. Global Postmenopausal Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Bisphosphonates
  • Vitamin D3
  • Estrogen Agonist Or Antagonist
  • Hormone Replacement Therapy
  • Parathyroid Hormone Therapy
  • Other Drug Types
  • 6.2. Global Postmenopausal Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oral
  • Parenteral
  • Other Routes Of Administration
  • 6.3. Global Postmenopausal Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies
  • Other Distribution Channels

7. Postmenopausal Osteoporosis Treatment Market Regional And Country Analysis

  • 7.1. Global Postmenopausal Osteoporosis Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Postmenopausal Osteoporosis Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Postmenopausal Osteoporosis Treatment Market

  • 8.1. Asia-Pacific Postmenopausal Osteoporosis Treatment Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Postmenopausal Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Postmenopausal Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Postmenopausal Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Postmenopausal Osteoporosis Treatment Market

  • 9.1. China Postmenopausal Osteoporosis Treatment Market Overview
  • 9.2. China Postmenopausal Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Postmenopausal Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Postmenopausal Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Postmenopausal Osteoporosis Treatment Market

  • 10.1. India Postmenopausal Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Postmenopausal Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Postmenopausal Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Postmenopausal Osteoporosis Treatment Market

  • 11.1. Japan Postmenopausal Osteoporosis Treatment Market Overview
  • 11.2. Japan Postmenopausal Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Postmenopausal Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Postmenopausal Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Postmenopausal Osteoporosis Treatment Market

  • 12.1. Australia Postmenopausal Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Postmenopausal Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Postmenopausal Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Postmenopausal Osteoporosis Treatment Market

  • 13.1. Indonesia Postmenopausal Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Postmenopausal Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Postmenopausal Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Postmenopausal Osteoporosis Treatment Market

  • 14.1. South Korea Postmenopausal Osteoporosis Treatment Market Overview
  • 14.2. South Korea Postmenopausal Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Postmenopausal Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Postmenopausal Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Postmenopausal Osteoporosis Treatment Market

  • 15.1. Western Europe Postmenopausal Osteoporosis Treatment Market Overview
  • 15.2. Western Europe Postmenopausal Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Postmenopausal Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Postmenopausal Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Postmenopausal Osteoporosis Treatment Market

  • 16.1. UK Postmenopausal Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Postmenopausal Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Postmenopausal Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Postmenopausal Osteoporosis Treatment Market

  • 17.1. Germany Postmenopausal Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Postmenopausal Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Postmenopausal Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Postmenopausal Osteoporosis Treatment Market

  • 18.1. France Postmenopausal Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Postmenopausal Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Postmenopausal Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Postmenopausal Osteoporosis Treatment Market

  • 19.1. Italy Postmenopausal Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Postmenopausal Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Postmenopausal Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Postmenopausal Osteoporosis Treatment Market

  • 20.1. Spain Postmenopausal Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Postmenopausal Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Postmenopausal Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Postmenopausal Osteoporosis Treatment Market

  • 21.1. Eastern Europe Postmenopausal Osteoporosis Treatment Market Overview
  • 21.2. Eastern Europe Postmenopausal Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Postmenopausal Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Postmenopausal Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Postmenopausal Osteoporosis Treatment Market

  • 22.1. Russia Postmenopausal Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Postmenopausal Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Postmenopausal Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Postmenopausal Osteoporosis Treatment Market

  • 23.1. North America Postmenopausal Osteoporosis Treatment Market Overview
  • 23.2. North America Postmenopausal Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Postmenopausal Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Postmenopausal Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Postmenopausal Osteoporosis Treatment Market

  • 24.1. USA Postmenopausal Osteoporosis Treatment Market Overview
  • 24.2. USA Postmenopausal Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Postmenopausal Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Postmenopausal Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Postmenopausal Osteoporosis Treatment Market

  • 25.1. Canada Postmenopausal Osteoporosis Treatment Market Overview
  • 25.2. Canada Postmenopausal Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Postmenopausal Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Postmenopausal Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Postmenopausal Osteoporosis Treatment Market

  • 26.1. South America Postmenopausal Osteoporosis Treatment Market Overview
  • 26.2. South America Postmenopausal Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Postmenopausal Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Postmenopausal Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Postmenopausal Osteoporosis Treatment Market

  • 27.1. Brazil Postmenopausal Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Postmenopausal Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Postmenopausal Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Postmenopausal Osteoporosis Treatment Market

  • 28.1. Middle East Postmenopausal Osteoporosis Treatment Market Overview
  • 28.2. Middle East Postmenopausal Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Postmenopausal Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Postmenopausal Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Postmenopausal Osteoporosis Treatment Market

  • 29.1. Africa Postmenopausal Osteoporosis Treatment Market Overview
  • 29.2. Africa Postmenopausal Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Postmenopausal Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Postmenopausal Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Postmenopausal Osteoporosis Treatment Market Competitive Landscape And Company Profiles

  • 30.1. Postmenopausal Osteoporosis Treatment Market Competitive Landscape
  • 30.2. Postmenopausal Osteoporosis Treatment Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Johnson and Johnson
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. F. Hoffmann-La Roche AG
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Merck and Co. Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. AbbVie Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Postmenopausal Osteoporosis Treatment Market Other Major And Innovative Companies

  • 31.1. Bayer AG
  • 31.2. Novartis AG
  • 31.3. Sanofi SA
  • 31.4. Eli Lilly and Company
  • 31.5. Amgen Inc.
  • 31.6. Asahi Kasei Corporation
  • 31.7. Viatris Inc.
  • 31.8. Teva Pharmaceutical Industries Ltd.
  • 31.9. Mylan N.V.
  • 31.10. Sandoz International GmbH
  • 31.11. Fresenius Kabi AG
  • 31.12. Daiichi Sankyo Company Ltd.
  • 31.13. Sun Pharmaceutical Industries Ltd.
  • 31.14. Cipla Inc.
  • 31.15. Dr.Reddys Laboratories Ltd.

32. Global Postmenopausal Osteoporosis Treatment Market Competitive Benchmarking

33. Global Postmenopausal Osteoporosis Treatment Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Postmenopausal Osteoporosis Treatment Market

35. Postmenopausal Osteoporosis Treatment Market Future Outlook and Potential Analysis

  • 35.1 Postmenopausal Osteoporosis Treatment Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Postmenopausal Osteoporosis Treatment Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Postmenopausal Osteoporosis Treatment Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer